🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

OrthoPediatrics Corp.

KIDS Healthcare
$24.48 $-0.59 (-2.35%)
Market Cap: $639.69 M
Gurus Holding
3
Popularity Rank
#3042
% of Shares Held
1.04%
Net Activity (Q2 2026)
+$1.27 M

Guru Ownership Trend

Guru Analysis for OrthoPediatrics Corp. (KIDS)

OrthoPediatrics Corp. (KIDS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.64 M.

Top institutional holders include Paul Tudor Jones and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $1.27 M net inflow during the quarter.

Recent activity highlights Cliff Asness who opened a new position. Conversely, Steven Cohen reduced exposure by 35.6%.

Key Holders

Top 5 by Value

$1.5 M
$442,400

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$1.52 M
Total Buy Value
New Buys 1
Additions 1
-$244,997.7
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for OrthoPediatrics Corp. (KIDS)

Major holders include Paul Tudor Jones ($3.25 M), Cliff Asness ($1.5 M), Steven Cohen ($442,400). According to the latest reported data, 3 tracked investment managers collectively hold approximately 271,439 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.27 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KIDS. The total reported sell value was $244,997.7.

Yes, 1 managers opened new positions in KIDS, and 1 increased their existing holdings. The total reported buy value was $1.52 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 0.6% 170,022 $3.25 M Q2 2026
0.00% New Buy 78,291 $1.5 M Q2 2026
0.00% Reduce -35.6% 23,126 $442,400 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form